Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
11:06
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

 

International Liver Cancer Association 14th Annual Conference

 

September 11-13, 2020 Virtual Conference
FAQs
   
Discussion forum - International Liver Cancer Association 20th Annual Conference
    Topic - Therapy & Miscellaneous

If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER.
 

Poster: 137
Visits: 36
Title: Total Tumor Volume As A Prognostic Value For Survival Following Liver Resection In Patients With Hepatocellular Carcinoma. Retrospective Cohort Study
Authors: Mohamed Abdel-Samiee , Hazem M. Zakariaa,&8727;, Mahmoud Macshuta, Nahla K. Gaballab, Ahmed E. Sherifa,Mohammed E. Abdel-Sameac, Ibrahim Marwana, Taha Yasseinaa Department of Hepatopancreatobiliary and Liver Transplant Surgery, National Liver Institute, Menoufia University, Menoufia, Egyptb Department of Anesthesia and Intensive Care, National Liver Institute, Menoufia University, Menoufia, Egyptc Department of Diagnostic and Intervention Radiology, National Liver Institute, Menoufia University, Menoufia, Egypt
Centre: 

You must be registered to reply or comment.

TOTAL TUMOR VOLUME AS A PROGNOSTIC VALUE FOR SURVIVAL FOLLOWING LIVER RESECTION IN PATIENTS WITH HEPATOCELLULAR CARCINOMA. RETROSPECTIVE COHORT STUDY

Mohamed Abdel-Samiee
Thread initiator
Subspeciality
Reg: 1/21/2020 1:24:00 AM

Comment# 1

I invite healthcare professionals to open debate around the issues raised in my poster, both those relating to research and to clinical practice.

Comment added on 9/22/2020 1:28:00 PM 
     
You must be registered to reply or comment.



Most viewed poster for this congress
Poster: 1
Visits: 241
Title: Pembrolizumab In Combination With Gemcitabine And Cisplatin For The Treatment Of Advanced Biliary Tract Cancer: Phase 3 Keynote-966 Trial In Progress
Authors: Robin Kelley , R.K. KELLEY, A. VOGEL, R.S. FINN, J. FURUSE, J. EDELINE, Z. REN, S.-C. SU, U. MALHOTRA, A.B. SIEGEL, J.W. VALLE
Centre: 

Poster most viewed in this topic
Poster: 103
Visits: 115
Title: Exposure-response analysis for nivolumab ipilimumab combination therapy in patients with advanced hepatocellular carcinoma (CheckMate 040)
Authors: Bruno Sangro ,
Centre: 


 




PosterSessionOnline
Logo Draft
 
Logo Cert